As a prestigious, international journal in the field of oncology, Cancer Communications publishes basic, clinical, and translational cancer research. It enjoys a large readership and is widely respected as the official journal of the Chinese Anti-Cancer Association and the US Chinese Anti-Cancer Association. With an average-time-to-first-decision after submission of just 25 days, the journal enables authors to comply with funder requirements on open access, and also waives the publication costs for selected, high quality articles. Cancer Communications is edited by an expert Editorial Board and a team of dedicated scientific editors.
Letter to the Editor
|Previous Title||Print ISSN||Online ISSN|
|Chinese Journal of Cancer||1944-446X|
To view the rest of this content please follow the download PDF link above.